Ucb Deutschland Is Likely A Subsidiary Of Ucba Multinational Biopharmaceutical Company Based In Brusselsbelgiumfounded In 1928Ucb Focuses On Developing Treatments For Neurological And Autoimmune Diseasesthe Company Reported A Revenue Of A 5 777 Billion In 2021 And Employs Approximately 7 600 People Ucb S Product Lineup Includes Treatments Such As Cimzia For Various Forms Of Arthritis And Crohn S Diseaseneupro For Parkinson S Disease And Restless Legs Syndromeevenity For Osteoporosisand Several Medications For Epilepsyincluding Vimpatkeppraand Briviactthe Company Emphasizes Research And Development In Severe Diseasesparticularly Those Affecting The Central Nervous System And Inflammatory Disorders
No conferences found for this company.
| Company Name | Schwarz Pharma Deutschland Gmbh |
| Country |
Germany
|
| Address | N/A |
| Telephone | N/A |
| N/A |
